Environmental, Social And Governance Report (Chinese edition)

Overview

The report covers Shijiazhuang Yiling Pharmaceutical Co., Ltd. headquarters and 65 subsidiaries for 2025. It evaluates 26 material ESG topics across impact and financial materiality, and reports total Scope 1 and Scope 2 emissions of 39,570.05 tCO2e. The company also describes energy-efficiency, photovoltaic and biogas projects and sets an overall carbon-neutral target before 2055.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: Chinese
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services